|
Nampt/Visfatin (rat) (recombinant) |
|
|
ALX-201-366-C010 |
|
10 µg |
295.00 USD |
|
 |
|
ALX-201-366-C050 |
|
50 µg |
795.00 USD |
|
 |
|
|
Nampt/Visfatin (rat) (recombinant) (His) |
|
|
ALX-201-332-C050 |
|
50 µg |
395.00 USD |
|
 |
|
|
Nampt/Visfatin (human) ELISA Kit |
|
|
AG-V0523EK-KI01 |
|
96 wells |
660.00 USD |
|
 |
|
AG-V0523TP-KI01 |
Twin Plex |
2x96 wells |
920.00 USD |
|
 |
|
AG-V0523PP-KI01 |
Penta Plex |
5x96 wells |
2'050.00 USD |
|
 |
|
|
Nampt/Visfatin (human) (IntraCellular) ELISA Kit |
|
|
AG-N0823EK-KI01 |
|
96 wells |
640.00 USD |
|
 |
|
AG-N0823TP-KI01 |
Twin Plex |
2x96 wells |
940.00 USD |
|
 |
|
|
Nampt/Visfatin (mouse) ELISA Kit |
|
|
AG-VN0812EK-KI01 |
|
96 wells |
660.00 USD |
|
 |
|
AG-VN0812TP-KI01 |
Twin Plex |
2x96 wells |
920.00 USD |
|
 |
|
AG-VN0812PP-KI01 |
Penta Plex |
5x96 wells |
2'050.00 USD |
|
 |
|
|
Naproxen |
|
|
ALX-270-102-G005 |
|
5 g |
35.00 USD |
|
 |
|
|
NBD Peptide / NF-κB Blocker (cell permeable) |
|
|
ALX-163-011-1 |
|
1 Vial |
240.00 USD |
|
 |
|
|
Neobavaisoflavone |
|
|
ALX-350-146-M001 |
|
1 mg |
170.00 USD |
|
 |
|
|
Netropsin . dihydrochloride |
|
|
ALX-380-088-M005 |
|
5 mg |
40.00 USD |
|
 |
|
|
NF-κB (p50) (human) (recombinant) (His) |
|
|
ALX-201-285-C002 |
|
2 µg |
280.00 USD |
|
 |
|
|
NF-κB (p65) (human) (recombinant) (His) |
|
|
ALX-201-284-C002 |
|
2 µg |
280.00 USD |
|
 |
|
|
Nicotinamide |
|
|
ALX-460-008-G010 |
|
10 g |
10.00 USD |
|
 |
|
|
Nicotinic acid |
|
|
ALX-460-009-G010 |
|
10 g |
13.00 USD |
|
 |
|
|
Nigericin . sodium salt |
|
|
ALX-380-050-M005 |
|
5 mg |
50.00 USD |
|
 |
|
ALX-380-050-M025 |
|
25 mg |
200.00 USD |
|
 |
|
|
8-Nitroguanine |
|
|
ALX-480-058-M001 |
|
1 mg |
120.00 USD |
|
 |
|
|
NMNAT1 (human) (recombinant) (His) |
|
|
ALX-201-237-C100 |
|
100 µg |
390.00 USD |
|
 |
|
|
NMNAT1 (human) (recombinant) (His) |
|
|
ALX-201-429-C010 |
|
10 µg |
140.00 USD |
|
 |
|
ALX-201-429-C050 |
|
50 µg |
280.00 USD |
|
 |
|
|
NMNAT3 (human) (recombinant) |
|
|
ALX-201-238-C100 |
|
100 µg |
390.00 USD |
|
 |
|
|
Norfloxacin |
|
|
ALX-380-295-G001 |
|
1 g |
20.00 USD |
|
 |
|
ALX-380-295-G005 |
|
5 g |
50.00 USD |
|
 |
|
|
Norfloxacin nicotinate |
|
|
ALX-380-296-G001 |
|
1 g |
20.00 USD |
|
 |
|
ALX-380-296-G005 |
|
5 g |
50.00 USD |
|
 |
|
|
Novobiocin . sodium salt |
|
|
ALX-380-093-G001 |
|
1 g |
30.00 USD |
|
 |
|
|
NU1025 |
|
|
ALX-270-370-M001 |
|
1 mg |
30.00 USD |
|
 |
|
ALX-270-370-M005 |
|
5 mg |
90.00 USD |
|
 |
|
ALX-270-370-M025 |
|
25 mg |
290.00 USD |
|
 |
|
|
Nullscript |
|
|
ALX-270-302-M001 |
|
1 mg |
50.00 USD |
|
 |
|
ALX-270-302-M005 |
|
5 mg |
200.00 USD |
|
 |
|
|
3-O-Acetyl-β-boswellic acid |
|
|
ALX-350-308-M001 |
|
1 mg |
45.00 USD |
|
 |
|
ALX-350-308-M005 |
|
5 mg |
180.00 USD |
|
 |
|
|
Ofloxacin |
|
|
ALX-380-297-G005 |
|
5 g |
45.00 USD |
|
 |
|
|
N-Oleoyldopamine |
|
|
ALX-550-398-M005 |
|
5 mg |
35.00 USD |
|
 |
|
|
Oleoylethanolamide |
|
|
ALX-300-150-M005 |
|
5 mg |
30.00 USD |
|
 |
|
|
Oxamflatin |
|
|
ALX-270-379-M001 |
|
1 mg |
70.00 USD |
|
 |
|
ALX-270-379-M005 |
|
5 mg |
275.00 USD |
|
 |
|
 |
|
|
Oxaspirodion |
|
|
ALX-350-301-MC05 |
|
0.5 mg |
290.00 USD |
|
 |
|
|
Panepoxydone |
|
|
ALX-350-109-MC05 |
|
0.5 mg |
390.00 USD |
|
 |
|
|
PARG (bovine) |
|
|
ALX-202-045-UC01 |
|
0.1 U |
375.00 USD |
|
 |
|
|
PARP-1 (bovine) (~90%) |
|
|
ALX-202-042-C010 |
|
10 µg |
180.00 USD |
|
 |
|
|
PARP-1 (bovine) (~98%) |
|
|
ALX-202-046-C010 |
|
10 µg |
250.00 USD |
|
 |
|
|
PARP-1 (bovine) (automodified) Standard |
|
|
ALX-202-044-R100 |
|
100 µl |
70.00 USD |
|
 |
|
|
PARP-1 (human) (recombinant) (high purity) |
|
|
ALX-201-063-C020 |
|
20 µg |
348.00 USD |
|
 |
|
|
PARP-1 (E988K mutant) (human) (recombinant) (Control) |
|
|
ALX-201-254-C010 |
|
10 µg |
180.00 USD |
|
 |
|
|
PARP-1 (human) (recombinant) (high purity) (His) |
|
|
ALX-201-250-C010 |
|
10 µg |
240.00 USD |
|
 |
|
|
PARP-1 (BRCT Domain) (human) (recombinant) (His) |
|
|
ALX-201-255-C020 |
|
20 µg |
290.00 USD |
|
 |
|
|
PARP-1 (Catalytic Domain) (human) (recombinant) (His) |
|
|
ALX-201-232-C020 |
|
20 µg |
380.00 USD |
|
 |
|
|
PARP-1b (human) (recombinant) (active) (His) |
|
|
ALX-201-253-C020 |
|
20 µg |
240.00 USD |
|
 |
|
|
PARP-2 (mouse) (recombinant) (high purity) |
|
|
ALX-201-064-C020 |
|
20 µg |
368.00 USD |
|
 |
|
|
PARP-2 (mouse) (recombinant) (high purity) (His) |
|
|
ALX-201-251-C010 |
|
10 µg |
240.00 USD |
|
 |
|
|
PARP-3 (human) (recombinant) (high purity) |
|
|
ALX-201-170-C020 |
|
20 µg |
368.00 USD |
|
 |
|
|
PARP-3 (human) (recombinant) (high purity) (His) |
|
|
ALX-201-252-C010 |
|
10 µg |
240.00 USD |
|
 |
|
|
Parthenolide |
|
|
ALX-350-258-M005 |
|
5 mg |
15.00 USD |
|
 |
|
ALX-350-258-M025 |
|
25 mg |
30.00 USD |
|
 |
|
|
PAz-PC |
|
|
ALX-300-301-M001 |
|
1 mg |
55.00 USD |
|
 |
|
ALX-300-301-M005 |
|
5 mg |
245.00 USD |
|
 |
|
|
PCAF (mouse) (recombinant) (His) |
|
|
ALX-201-281-C020 |
|
20 µg |
280.00 USD |
|
 |
|
|
Pefloxacin . mesylate . dihydrate |
|
|
ALX-380-298-G005 |
|
5 g |
30.00 USD |
|
 |
|
|
Peroxynitrite . tetramethylammonium |
|
|
ALX-400-036-L001 |
|
1 ml |
152.00 USD |
|
 |
|
ALX-400-036-5001 |
|
5x1 ml |
475.00 USD |
|
 |
|
|
6(5H)-Phenanthridinone |
|
|
ALX-270-251-M010 |
|
10 mg |
15.00 USD |
|
 |
|
|
Phospho-IκBα ActivELISA™ Assay Kit |
|
|
ALX-850-286-KI01 |
|
1 Kit |
559.00 USD |
|
 |
|
|
Pioglitazone |
|
|
ALX-270-367-M001 |
|
1 mg |
48.00 USD |
|
 |
|
ALX-270-367-M005 |
|
5 mg |
190.00 USD |
|
 |
|
|
PJ-34 |
|
|
ALX-270-289-M001 |
|
1 mg |
50.00 USD |
|
 |
|
ALX-270-289-M005 |
|
5 mg |
125.00 USD |
|
 |
|
ALX-270-289-M025 |
|
25 mg |
375.00 USD |
|
 |
|
|
Podophyllotoxin |
|
|
ALX-630-086-M100 |
|
100 mg |
45.00 USD |
|
 |
|
|
Poly(ADP-ribose) Standard |
|
|
ALX-202-043-C001 |
|
1 µg |
230.00 USD |
|
 |
|
|
Polyclonal Antibody to 14-3-3ε (NT) |
|
|
ALX-215-025-R100 |
|
100 µl |
290.00 USD |
|
 |
|
|
Polyclonal Antibody to 14-3-3 (human) |
![]() |